PDS Biotechnology Corporation
NASDAQ:PDSB
3.28 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||
Current Assets: | |||||||||||
Cash & Cash Equivalents
| 56.561 | 73.82 | 65.243 | 28.84 | 12.162 | 34.646 | 88.068 | 106.399 | 130.189 | 13.729 | 7.858 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 56.561 | 73.82 | 65.243 | 28.84 | 12.162 | 34.646 | 88.068 | 106.399 | 130.189 | 13.729 | 7.858 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.459 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 2.495 | 2.66 | 1.598 | 1.498 | 2.308 | 1.006 | 0.987 | 0.955 | 1.081 | 1.405 | 0.213 |
Total Current Assets
| 59.055 | 76.48 | 66.84 | 30.337 | 14.47 | 35.651 | 89.054 | 107.354 | 131.271 | 15.442 | 8.53 |
Non-Current Assets: | |||||||||||
Property, Plant & Equipment, Net
| 0.335 | 0.528 | 0.358 | 0.553 | 0.021 | 0.427 | 3.424 | 3.418 | 2.767 | 1.444 | 0.14 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0.047 | 0.052 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0.047 | 0.052 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| -0 | 0 | 0 | -0 | -0 | 0.143 | 0.096 | 0.091 | 0.055 | 0.161 | 0.064 |
Total Non-Current Assets
| 0.335 | 0.528 | 0.358 | 0.553 | 0.021 | 0.57 | 3.567 | 3.561 | 2.822 | 1.605 | 0.204 |
Total Assets
| 59.39 | 77.008 | 67.198 | 30.89 | 14.491 | 36.221 | 92.621 | 110.914 | 134.093 | 17.047 | 8.734 |
Liabilities & Equity: | |||||||||||
Current Liabilities: | |||||||||||
Account Payables
| 6.983 | 1.219 | 1.309 | 1.415 | 1.198 | 0.399 | 4.369 | 3.471 | 2.584 | 2.046 | 1.087 |
Short Term Debt
| 4.222 | 0.288 | 0.259 | 0.12 | 0 | 0 | 3.075 | -0.007 | 2.271 | 0.265 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0.025 | 0.007 | 0.034 | -0.265 | 0 |
Other Current Liabilities
| 2.425 | 8.314 | 2.188 | 1.735 | 1.596 | 5.982 | 5.397 | 3.214 | 3.7 | 1.847 | 0.701 |
Total Current Liabilities
| 13.63 | 9.821 | 3.756 | 3.27 | 2.794 | 6.382 | 12.867 | 6.685 | 8.59 | 3.893 | 1.788 |
Non-Current Liabilities: | |||||||||||
Long Term Debt
| 19.506 | 23.185 | 0.231 | 0.49 | 0 | 0.03 | 17.383 | 14.953 | 3.025 | 2.528 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.123 | 0 | 0 | 0 | 0 | 0.291 | 0 | -0 | 0 | 38.46 | 22.295 |
Total Non-Current Liabilities
| 19.629 | 23.185 | 0.231 | 0.49 | 0 | 0.321 | 17.383 | 14.953 | 3.025 | 40.987 | 22.295 |
Total Liabilities
| 33.259 | 33.006 | 3.987 | 3.761 | 2.794 | 6.382 | 30.25 | 21.638 | 11.615 | 44.88 | 24.083 |
Equity: | |||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.011 | 0.01 | 0.009 | 0.007 | 0.002 | 0.011 | 0.01 | 0.01 | 0.01 | 0.001 | 0.001 |
Retained Earnings
| -144.501 | -101.558 | -60.704 | -43.785 | -28.938 | -192.816 | -151.948 | -101.075 | -62.254 | -29.819 | -16.037 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -0.452 | -0.305 | -0.122 | -0.091 | -0.038 | -0.007 |
Other Total Stockholders Equity
| 170.621 | 145.55 | 123.905 | 70.907 | 40.634 | 223.097 | 214.615 | 190.464 | 184.813 | 2.023 | 0.693 |
Total Shareholders Equity
| 26.131 | 44.002 | 63.21 | 27.13 | 11.698 | 29.839 | 62.371 | 89.277 | 122.478 | -27.834 | -15.35 |
Total Equity
| 26.131 | 44.002 | 63.21 | 27.13 | 11.698 | 29.839 | 62.371 | 89.277 | 122.478 | -27.834 | -15.35 |
Total Liabilities & Shareholders Equity
| 59.39 | 77.008 | 67.198 | 30.89 | 14.491 | 36.221 | 92.621 | 110.914 | 134.093 | 17.047 | 8.734 |